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Extracellular vesicles (EVs) have been lauded as next-generation medicines, but very
few EV-based therapeutics have progressed to clinical use. Limited clinical translation
is largely due to technical barriers that hamper our ability to mass produce EVs, i.e., to
isolate, purify, and characterize them effectively. Technical limitations in comprehensive
characterization of EVs lead to unpredicted biological effects of EVs. Here, using
a range of optical and non-optical techniques, we showed that the differences in
molecular composition of EVs isolated using two isolation methods correlated with
the differences in their biological function. Our results demonstrated that the isolation
method determines the composition of isolated EVs at single and sub-population levels.
Besides the composition, we measured for the first time the dry mass and predicted
sedimentation of EVs. These parameters were likely to contribute to the biological
and functional effects of EVs on single cell and cell cultures. We anticipate that our
new multiscale characterization approach, which goes beyond traditional experimental
methodology, will support fundamental understanding of EVs as well as elucidate the
functional effects of EVs in in vitro and in vivo studies. Our findings and methodology will
be pivotal for developing optimal isolation methods and establishing EVs as mainstream
therapeutics and diagnostics. This innovative approach is applicable to a wide range of
sectors including biopharma and biotechnology as well as to regulatory agencies.
Keywords: extracellular vesicles, mesenchymal stromal/stem cell, isolation methods, ultracentrifugation,
tangential flow filtration, nanodosimetry, single vesicle analysis, exosomes
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INTRODUCTION
Current medicine has only taken us so far in reducing disease
and the tissue damage that it causes. Extracellular vesicles
(EVs) have been hailed as the next generation of medicines.
EVs are membrane-surrounded nanoscale structures secreted
ubiquitously by cells. They contain multiple substances that
influence the function of surrounding cells (Lötvall et al., 2014;
Iraci et al., 2016). Since EV composition reflects the composition
of the parent cell, EVs are ideal candidates for use in disease
diagnosis (Candelario and Steindler, 2014). EVs are already
considered as diagnostic biomarkers for cancer, cardiovascular,
neurodegeneration, and kidney diseases (Taylor and Gercel-
Taylor, 2008; Candelario and Steindler, 2014; Danielson and Das,
2014). It is also well established that EVs transfer numerous
molecules including proteins, lipids, and nucleic acids between
cells, and these molecules can act synergistically and influence the
behavior of surrounding cells (Yanez-Mo et al., 2015). Since EVs
can deliver multiple molecules to reprogram the injured cells and
mediate the de-differentiation of cells, EVs can be used for tissue
repair/regeneration (Guo et al., 2011). EVs derived from stem
cells are recognized as “second generation” stem cell therapies
(Candelario and Steindler, 2014; György et al., 2015)—made by
cells for cells. Compared with stem cells, EVs have key advantages
including low immunogenicity, no ability to self-replicate (no risk
of cancer), high resistance to hostile environments, and improved
bioactivity and stability upon storage (Piffoux et al., 2017).
However, despite all these potential advantages, very few EV
applications have progressed to clinical use (Yekula et al., 2020).
The limited clinical translation of EVs is largely due to
technical barriers that hamper the mass production of EVs, i.e.,
the ability to isolate, purify, and characterize them effectively
at single vesicle (nano), sub-population, and population levels
(Ramirez et al., 2018). Since EV sizes range from 50 to 150 nm
and they are secreted into rich multicomponent media or
body fluids, isolation and characterization are not trivial and
remain as key challenges in the field (Ramirez et al., 2018).
The molecular corona, which cloaks EVs and is likely to cover
some of the surface markers, adds to the complexity of these
challenges (Simonsen and Munter, 2020). Since the corona
changes the physicochemical characteristics of EVs and their
affinity to the substrates used in some isolation methods, it is
difficult to isolate and characterize EVs effectively. Moreover, EV
isolates often contain lipoproteins, protein aggregates, and non-
vesicle macromolecules (Sunkara et al., 2016). We also know
that cell-free DNA can adsorb to lipid nanoparticles (Gardner
et al., 2020), which is likely to occur for circulating EVs too,
but surprisingly, this phenomenon is largely overlooked in the
field. These “contaminants” influence the biological function
Abbreviations: AFM, atomic force microscopy; AFM-IR, atomic force microscope
infrared-spectroscopy; CMSC29, chorionic mesenchymal stromal/stem cell line;
CEVs, extracellular vesicles derived from chorionic mesenchymal stromal/stem
cell; DMSC23, decidual mesenchymal stromal/stem cell line; DEVs, extracellular
vesicles derived from decidual mesenchymal stromal/stem cell; EVs, extracellular
vesicles; HBSS(-), Hank’s balanced salt solution; LPS, lipopolysaccharide; MSC,
mesenchymal stromal/stem cell; PTA, particle tracking analysis; nFCM, nano-
flow cytometry; RMM, resonant mass measurement; TRPS, tunable resistive pulse
sensing; TFF, tangential flow filtration.
of EVs and are not trivial to detect due to the sensitivity of
experimental methods. This also means that it is difficult to
decouple them from the isolated EV populations (Mateescu
et al., 2017). However, these contaminants could potentially
work synergistically with EVs to achieve specific therapeutic
function in the body (Thery et al., 2018). Therefore, for practical
utilization of isolation protocols, it is necessary first to perform
comprehensive physicochemical and molecular characterization
of EV isolates at sub/population and single vesicle levels and to
measure functional responses to EVs in adequate cell/animal-
based models.
The most commonly used approach to isolate EVs is
ultracentrifugation, which involves multistep differential
centrifugations to pellet vesicles (Ismail et al., 2013; Gardiner
et al., 2016). However, ultracentrifugation is labor intensive,
requires large sample volumes, and produces a relatively low
yield of enriched EVs (Kang et al., 2017). Numerous alternative
isolation methods have been developed including density
gradients (DG) and size exclusion chromatography (SEC).
Although DG and SEC usually result in high-purity EV, these
protocols are time consuming, characterized by poor yields and
suitable for small input volumes only (less than 5 ml) (Witwer
et al., 2013; Coumans et al., 2017). Immunoaffinity-based
approaches can also be used for EV isolation (Li et al., 2019). In
these approaches, EVs are “collected” by beads functionalized
with EV-specific antibodies; thus, the isolation process is solely
related to affinity of EVs to selected antibodies. The collection of
EVs is based on the assumption that specific markers are present
on the surface of EVs. This means that these approaches are
highly selective and likely to isolate only some fractions of EV
populations. More importantly, these methods fail to account
for the aforementioned corona making these approaches even
more selective (Simonsen and Munter, 2020). Furthermore, at
this stage, only small quantities of biological samples can be
processed in immunoaffinity-based isolation (Momen-Heravi
et al., 2013). In contrast, tangential flow filtration (TFF) is
capable of processing scalable volumes of biological fluids and
producing high EV yield (Busatto et al., 2018). TFF is technically
simple to operate and requires low-cost instrumentation. These
features make TFF well suited to isolate EVs at large scale.
However, to enable broader applications of TFF, its advantages
in comparison with ultracentrifugation (and other methods)
must be determined.
Previous studies investigated the differences in
physical properties between EVs isolated using TFF and
ultracentrifugation (Busatto et al., 2018; Heath et al.,
2018). However, the results are limited to selected physical
characteristics of EVs (e.g., yield, size distribution, morphology,
and surface markers) and do not show their correlation with
biological effects. To the best of our knowledge, there is
no available studies investigating how the physicochemical
properties of EVs contribute to the EV functionality. Here,
using a combination of high-resolution optical and non-optical
techniques, as well as functional assays, we interrogated the
differences between EVs isolated using ultracentrifugation and
TFF at single vesicle, sub-population, and population levels.
The significance of this work is in a new methodology, which
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enables characterizing EVs and demonstrating how the isolation
methods influence the physicochemical/molecular composition
of EVs and functional cell responses to EVs. For the first time,
we measured the dry mass of large EVs or EV agglomerates
(>100 nm), predicted the sedimentation of EVs, and developed a
new fluorescent probe to assess the functionality of EVs. The key
strength of this study lies in the comprehensive characterization
of EVs at single vesicle, EV sub-population, and EV population
levels, as well as in the analysis of cellular responses (i.e., EV
uptake) at single-cell level. To achieve desired statistical and
scientific validation of our approach, we used two cell types,
which produce different quantities of EVs and that these EVs
characterize with different molecular cargo; specifically, we used
chorionic and decidual mesenchymal stem cells (CMSC29 and
DMSC23, respectively) (Qin et al., 2016; Kim et al., 2019a).
Our study provides evidence that EVs’ physicochemical
characteristics (at single vesicle, subpopulation, and population
level) as well as their biological function, depends on the isolation
method. The differences in physicochemical properties of EVs
were shown to correlate well with the functional effects of EVs.
We concluded that isolation method determines the composition
of EV isolates. These findings are of critical significance in
the field because they suggest that isolation method is pivotal
in establishing downstream applications of EV as diagnostic
biomarkers, therapeutics, and in fundamental biology. Notably,
this work highlights the importance of nanoscale and single-
particle characterization methods in EV research and the need
for the integrated use of physicochemical and functional assays.
MATERIALS AND METHODS
Cell Culture and Maintenance
Both chorionic and decidual MSCs cell lines (CMSC29 and
DMSC23) were obtained from the Royal Women’s Hospital in
Melbourne, Australia. Telomerase reverse transcriptase (hTERT)
was transduced into primary MSCs from the fetal chorion and
maternal decidual components of human placenta to create
the CMSC29 and DMSC23 cell lines, respectively (Qin et al.,
2016). Since CMSC29 and DMSC23 were derived from different
parts of the placenta, they are exposed to different levels of
oxidative stress (Kusuma et al., 2016); thus, they required
different types of medium. CMSC29 cells were cultured in 85%
AmnioMAXTM C-100 basal medium and 15% AminoMAXTM
C-100 supplement (InvitrogenTM, ThermoFisher Scientific).
DMSC23 cells were cultured in MesenCultTM MSC basal
medium (Human), 10% Mesenchymal stem cell stimulatory
supplement (STEMCELL Technologies, Canada), GlutaMAXTM
(Life Technologies, Australia), and antibiotics (Pen/Strep) (100 U
of penicillin and 0.1 mg/ml of streptomycin, Sigma-Aldrich,
Australia). BEAS-2B cells were cultured in medium containing
Dulbecco’s modified Eagle’s medium (DMEM medium-high
glucose, Sigma-Aldrich, Australia) supplemented with 10%
fetal bovine serum (FBS, Bovogen, Australia), and antibiotics
(Pen/Strep). Cells were sub-cultured every 2–3 days and
maintained in the incubator at 37◦C supplemented with 5% CO2.
Hanks’ balanced salt solution (HBSS, Sigma-Aldrich, Australia)
was used for washing CMSC29 and DMSC23 cells. TrypLETM
Express (Gibco, Denmark) was used to dissociate the adherent
cells. EV isolation and collection were from CMSC29 and
DMSC23 cells at passages P23–28.
Isolation of Extracellular Vesicles by
Ultracentrifugation
CMSC29 and DMSC23 cells were cultured to 80% confluency.
Cells were washed twice with HBSS before incubating cells
with EV isolation media (MesenCultTM MSC basal medium)
containing 0.5% (w/v) bovine serum albumin (BSA, Sigma-
Aldrich, Australia) for 48 h. After 48 h, EV-containing media
was collected and centrifuged at 500 × g for 5 min and
2,000× g for 10 min to remove cells and debris. The supernatant
was then transferred to thick-wall polycarbonate ultracentrifuge
tubes (Seton Scientific Inc, United States) and centrifuged at
100,000 × g for 60 min at 4◦C using rotor Ti-70 in an Optima
LE-80K Ultra Centrifuge (Beckman Coulter, Australia). The
harvested EV pellet was resuspended in 1 ml of RNase-free
phosphate-buffered saline (RNase-free PBS, Lonza, Australia)
and washed using ultracentrifugation at 100,000× g for 60 min at
4◦C. The pellet was resuspended in 1 ml of RNase-free PBS and
transferred to RNase-free microcentrifuge tubes. The EV pellets
were stored at 4◦C to avoid losing biological function during the
freezing process.
Isolation of Extracellular Vesicles by
Tangential Flow Filtration
After removing cells and debris by centrifugation at 500 × g
(5 min) and 2,000 × g (10 min) as described above, the EV
containing supernatant was filtered (0.45 µm) and transferred to
TFF-Easy 20-nm pores (HansaBioMed/Lonza, Tallinn, Estonia)
for EV concentration. The EV concentration process was
described in the manufacturer’s protocol (HansaBioMed/Lonza),
and EVs were finally diafiltrated in RNase-free PBS.
Size and Concentration Measurement
Using Nano-Flow Cytometry
The size and concentration of EVs were measured using
NanoFCM (Xiamen Fuliu Biological Technology Co., Ltd,
Xiamen, China). A mixture of silica nanospheres (68, 91, 113,
and 155 nm) was used as the size standard for the construction
of a calibration curve and standard 200-nm polystyrene spheres
were used for laser alignment. All events were collected for
120 s, and size (SSC) triggering was used to detect EVs.
The total events collected ranged from 3,000 to 6,000 events.
The representative histogram was conducted from triplicate
measurements of each EV sample.
Size and Concentration Measurement
Using Particle Tracking Analysis
EV samples were diluted with RNase-free water to achieve
a concentration between 1 × 108 and 1 × 109 EVs/ml and
measured using a NanoSight NS300 (Malvern Panalytical Ltd,
Malvern, United Kingdom). A syringe pump with a speed of
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40 µl/min was used, and cell temperature was set at 25◦C.
Embedded laser wavelength was 488 nm, and the particles were
imaged with an auto-focus camera for 60 s. Data were obtained
at camera-level 11. The analysis settings were set to “auto,”
and the detection threshold was set to 5 in the NanoSight
Software NTA (version 3.2) to assess mean and modal particle
diameters, D50 values (which represents the 50th percentile of the
averaged cumulative number-weighted particle size distribution)
and particle number concentration. For each EV sample, three
repeat measurements were conducted.
Size Measurement Using Dynamic Light
Scattering
EV samples were diluted in RNase-free water to achieve a
particle concentration ranging from 1 × 109 to 1 × 1010 EVs/ml
and were measured in a Zetasizer Ultra (Malvern Panalytical
Ltd, Malvern, United Kingdom). The manufacturer’s default
software setting for EVs (liposomes) was selected, and three
cycles were performed for each measurement at 4◦C. Data were
analyzed using general purpose mode in ZS XPLORER software
(version 1.2.0.91), and the size distribution of EV populations was
presented as a percentage of intensity. Three consecutive runs
were performed for each sample.
Size and Concentration Measurement
Using Tunable Resistive Pulse Sensing
TRPS was performed using a qNano (IZON, New Zealand) to
measure the particle size and the concentration of EVs. EVs
were suspended in electrolytes and passed through an engineered
pore (NP100), which provided direct measurement of size and
concentration. Buffers and reagents were freshly prepared and
filtered (0.22 µm) before the measurement. The detailed protocol
for qNano measurements was described in the study by Vogel
et al. (2011). Three independent measurements were done for
each individual EV sample.
Morphology Analysis of Extracellular
Vesicles Using Atomic Force Microscopy
EV samples were placed onto zinc selenide prism,
dried overnight, and subsequently imaged using atomic
force microscopy (AnasysInstruments, United States).
Images were obtained in contact mode at a scan rate of
0.5 Hz using EX-T125 probe with nominal resonance
frequency 200–400 kHz and spring constant 13–77 Nm−1
(AnasysInstruments, United States).
Dry Mass Measurement of Extracellular
Vesicles Using Resonant Mass
Measurement
The buoyant mass of the particles was measured with the
Archimedes Particle Metrology System (Malvern Panalytical,
Malvern, United Kingdom). The microchannel sensor used
consisted of a microfluidic channel with a cross section of
2 × 2 µm2. In order to determine the dry mass and size
of the EVs from the measured buoyant mass, EVs of known
size were used to determine EV density. Monodisperse control
EVs with 200 nm diameter were measured, and a spherical
model was applied, from which a density of 1.4 g/cm3 was
determined (Supplementary Figure 1). The sensitivity factor of
the microchannel resonator was determined using monomodal
gold calibration particles (NIST RM 8016, 60 nm, United States).
From this sensitivity factor, the mass resolution of the sensor
is ∼10−15 g, which for EVs corresponds to a limit of detection
(LOD) of 100 nm.
Quantification of Extracellular Vesicle
Surface Markers Using nFCM
The monoclonal antibodies, anti-CD9 Alexa Fluor 488-
conjugated (R & D systems, Canada), anti-CD63 Alexa Fluor
488-conjugated (Invitrogen, ThermoFisher Scientific), or
anti-CD81 Alexa Fluor 488-conjugated (R & D systems,
Canada) were used to assess protein surface markers of EVs.
Approximately 1 × 1010 EVs/ml was stained using 8 µg/ml of
each antibody and incubated 30 min at 37◦C in dark condition.
The EV samples were then washed with 2 ml of RNase-free
PBS three times using ultracentrifugation 100,000 × g, 4◦C,
70 min each. The supernatants were carefully aspirated from
the bottom of the tubes in every wash. Subsequently, the
pellets were dissolved in RNase-free PBS, and the fluorescence
intensity was measured using a nFCM. The control sample
was the basal medium with 0.05% (w/v) BSA without EVs. All
fluorescence events were detected in FITC triggering of nFCM,
and the threshold level was set by default in NF Profession 1.0
acquisition software.
Quantification of Nucleic Acid Using
nFCM
EVs isolated using TFF and ultracentrifugation were stained
using 10 µM SYTO RNASelect green fluorescent cell stain
(InvitrogenTM, ThermoFisher Scientific) at 37◦C for 30 min.
The EV samples were loaded on the exosome spin column
MW 3000 (InvitrogenTM, ThermoFisher Scientific) to remove
unbound dyes and measured using nFCM. The control sample
was basal medium without EVs. All fluorescence events were
collected for 120 s and fluorescence (FITC) triggering of an
nFCM was used to detect fluorescence EVs. Data were analyzed
using FlowJo software (version 10.6). The threshold level was set
above the background level by the NF Profession 1.0 acquisition
software by default.
Quantification of Lipid Content Using
nFCM
PKH67 and Diluent C (ThermoFisher Scientific) was selected to
be the general membrane labeling for EVs. PKH67 was diluted
in 100 µl of Diluent C to a final concentration of 15 µM (dye
solution). Approximately 1 × 1010 EVs/ml were diluted with
80 µl of Diluent C, added to a dye solution, and incubated
for 3 min with gentle pipetting. Excess dye was bound with
10% (w/v) BSA in RNase-free water. The EV samples were then
diluted to 2 ml with RNase-free PBS and washed three times
using ultracentrifugation 100,000 × g, 4◦C, 70 min each. The
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pellet was gently resuspended in 100 µl of RNase-free PBS, and
nFCM was used to measure the fluorescence intensity of EVs.
The control sample was the basal medium only and the basal
medium with 0.05% (w/v) BSA without EVs. All fluorescence
events were triggered in the FITC channel and collected for
120 s. The threshold was set by default in NF Profession 1.0
acquisition software.
Molecular Composition Analysis of
Extracellular Vesicles Using Atomic
Force Nanoscale Infrared Spectroscopy
(AFM-IR)
The protocol for EV characterization using AFM-IR (nanoIR,
Anasys Instruments, United States) was described in our previous
study (Khanal et al., 2016). Briefly, each EV sample was placed
on a zinc selenide prism and dried overnight. The laser signal
was optimized before acquiring the nanoIR spectra ranging
from 1,000 to 1,800 cm−1 at 4-cm−1 intervals with a scan rate
of 0.5 Hz. A gold-coated tip and a silicon nitride cantilever
with a nominal spring constant of 0.5 Nm−1 were used for all
measurements. The acquired scan sizes were 10 × 5 µm for
each sample, and Analysis StudioTM software was used for data
analyses. The “Savitzky–Golay” function was used to achieve
smoothing of the spectra with the polynomial function of 3, and
eight numbers of points.
Measurement of Predicted
Sedimentation of Extracellular
Vesicles—Distorted Grid Model
The predicted transport modeling of TFF and ultracentrifugation
isolated EVs, which was originally applied for the engineered
nanomaterials (ENMs), was modified and adapted for EVs
(Cohen et al., 2014). Briefly, the protocol comprised three
interconnected parts: ENM dispersion preparation and
characterization in suspension, effective density calculation,
and delivered dose computation (Cohen et al., 2014). The
dispersion preparation and characterization were not applied to
EVs. The delivered dose metric was used to calculate the fraction
of administered EVs in a 96-well plate over 24 h. Data were
acquired using Matlab.
The effective density of EVs (ρeffective density) was determined
using the equation:
ρeffective density = ρmedia +
[(
MEV − MEVsol
VpelletSF
)(
1−
ρmedia
ρEV
)]
(1)
whereby:
ρmedia is the density of the medium (g/cm3).
MEV is the total mass of EVs (g) in the dispensed
volume of suspension.
MEVsol is the mass of dissolved EVs in the dispensed
volume of suspension.
Vpellet is the measured pellet size in centimeters squared
inside the PCV tube.
SF is the stacking factor, which is the portion of the pellet that
is composed of agglomerates (theoretical maximum of 0.74 for
ordered stacking).
ρEV is the density of EVs (g/cm3).
Visualization of Extracellular Vesicle
Uptake Using Holotomography and
Fluorescence Microscopy
CMSC29 EVs isolated using TFF and ultracentrifugation were
labeled with PKH67 followed the lipid staining protocol as
described in section ‘Quantification of Lipid Content Using
nFCM’. The staining of EVs was done 1 h prior to incubation.
Approximately 2 × 104 BEAS-2B cells were dosed with
1 × 109 PKH67-stained EVs/ml and incubated with the
dye for 3 h. Uptake of EVs by cells was performed on
a holotomography microscope Tomocube HT-2H (Tomocube
Inc., Daejeon, South Korea). A water immersion objective (60×,
N.A = 1.2) was used to acquire the images. Z-stacked images were
acquired across each field-of-view, with a minimum of four field-
of-views imaged for each type of EVs. The images were acquired
in TomoStudioTM 2.0 software, and they were further analyzed
using ImageJ FIJI.
Analysis of Cell Migration to Extracellular
Vesicle Treatment After
Lipopolysaccharides Injury
Cell migration in the presence of isolated EVs was measured
by comparing the area of closure of a two-dimensional scratch
wound. BEAS-2B cells were seeded at 1 × 104 cells per well
on Image Lock 96-well plates and allowed to adhere overnight.
“Injury” was induced using 10 µg/ml of lipopolysaccharides
(LPS) for 24 h (Xu and Zhou, 2020). A wound on the midline of
culture well was then created using a 96-pin wound making tool
(IncuCyte WoundMakerTM). After washing the cells with RNase-
free PBS once, EVs isolated using TFF and ultracentrifugation
were added at an ascending concentration ranging from 10 to
1,000 EVs per cell. Wound images were taken every 2 h with
a 10× magnification objective lens using the IncuCyte live cell
imaging system and IncuCyte ZOOM software program (Essen
BioScience, United States). Wound confluence (%), which was
represented as the wound closure (%), was assessed for all
images using IncuCyte ZOOM software. Data were analyzed
using GraphPad, and measurements of eight samples (n = 8) were
performed for each condition.
Analysis of Cellular Responses to
Extracellular Vesicle Treatment After
Lipopolysaccharide Injury
Cellular responses post-injury in the presence of TFF and
ultracentrifugation isolated EVs were assessed by measuring
intracellular nitric oxide (NO) levels. Approximately 5 × 103
BEAS-2B cells were seeded on a glass bottom dish precoated
in L-poline (MatTek) and allowed to adhere overnight. Cells
were then exposed to 10 µg/ml of LPS for 24 h. Cells were
next incubated with 50 µM NpNO1 probe for 24 h at 37◦C,
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at 5% CO2. Excess NpNO1 probe was washed and imaged in
FluoroBriteTM DMEM media (Gibco, ThermoFisher Scientific)
supplemented with 10% FBS and antibiotics (Pen/Strep). Samples
were imaged using Olympus FV3000 microscope equipped with
a 405-nm laser, a water 60× objective lens, and an incubator
stage maintained at 37◦C and 5% CO2. A minimum of three
field-of-views were imaged for each condition per experiment
with Z-stacked images per field-of-view. Maximum projected
micrographs of the Z-stacks were presented in this study. Regions
of interest were drawn around each cell, and mean fluorescence
intensities were quantified using ImageJ FIJI. Statistical analyses
were performed on the mean fluorescence intensity values and
plotted using GraphPad.
Statistical Analyses
Data were analyzed and presented as mean± standard deviation
(SD). For cell migration and cellular stress assays, a minimum
of three independent preparations of each sample were made
for each of the experiments (n = 3). Ordinary one-way
ANOVA followed by Dunn’s multiple comparison’s test for
pair-wise comparisons were used to determine the differences
between multiple groups. A P-value <0.05 is considered to be
statistically significant.
RESULTS
To measure EV size and concentration, we used particle tracking
analysis (PTA), dynamic light scattering (DLS) (size only),
nano-flow cytometry (nFCM), tunable resistive pulse sensing
(TRPS), and asymmetric flow-field fractionation (AF4) (size
only). Nanoscale infrared spectroscopy (AFM-IR) and nFCM
were used to determine EV composition at the single EV and
EV sub-population levels. For the first time, we used resonant
mass measurement (RMM) for the characterization of dry mass
and buoyant mass of large EVs (>100 nm) and distorted grid
(DG) for the sedimentation prediction of EVs. Sedimentation of
nanoparticles reveals the actual concentration of nanoparticles on
the cell surface, which correlates with cellular uptake (Momen-
Heravi et al., 2013). Therefore, sedimentation is the key factor
in the interpretation of downstream biological effects of EVs on
the cellular response. The actual functional effects of EV isolates
on cells were determined using newly developed nitric oxide
fluorescent probe to measure intracellular stress in an in vitro
model of acute lung injury.
Comparison of Extracellular Vesicle Size
Distribution and Concentration
Chorionic and decidual MSC cell lines (CMSC29 and DMSC23)
were used as cell sources to isolate EVs. EVs isolated from
CMSC29 and EVs isolated from DMSC23 cells were referred to
as CEVs and DEVs, respectively.
The size distribution of CEVs and DEVs was assessed using
four independent techniques: PTA, DLS, nFCM, and TRPS.
Particle Tracking Analysis
PTA analyses showed that both CEVs and DEVs isolated
using TFF and ultracentrifugation had a similar particle size
distribution ranging from 100 to 300 nm (Figures 1A,B).
However, there was a small peak at around 50 nm in the size
distribution spectrum of DEVs isolated using TFF, which was not
present in EVs isolated using ultracentrifugation (Figure 1B).
Dynamic Light Scattering
Size analyses using DLS showed that the intensity-based size
distribution of CEVs and DEVs, isolated using TFF and
ultracentrifugation, were different (Figures 1C,D). CEVs isolated
using TFF had one high-intensity peak at around 200 nm with
one low-intensity peak at approximately 8 nm. In contrast, CEVs
isolated using ultracentrifugation had one dominant peak at
around 300 nm (Figure 1C). The intensity-based size distribution
for DEVs isolated using TFF had two peaks at 8 and 200 nm,
while DEVs isolated using ultracentrifugation had one broad
peak at around 1,000 nm with one small shoulder at around
200 nm (Figure 1D).
The presence of small particles (around 8 nm) in CEVs
isolated using TFF was verified using preliminary asymmetric
flow-field fractionation (AF4) measurement (Supplementary
Figure 2). Since the elution peak of CEVs isolated using TFF at
18 min coincides with pure BSA, the small-size particles in CEVs
isolated using TFF were identified as BSA contaminants.
Overall, the size of both CEVs and DEVs isolated using
ultracentrifugation as assessed by DLS were larger than the EVs
isolated using TFF. This is likely to be related to the presence
of a few larger entities (potentially agglomerates during the
ultracentrifugation process). Since DLS is extremely sensitive
to the presence of large entities, even with a low amount of
these would account for the shape of the intensity-weighted data
(Bishop et al., 1991).
Nano-Flow Cytometry
nFCM measurements showed a broad size distribution ranging
from 50 to 200 nm for both CEVs and DEVs isolated using TFF
and ultracentrifugation (Figures 1E,F). While the size of most of
EVs isolated using TFF (for both CEVs and DEVs) was around
60 nm, the size of EVs isolated using ultracentrifugation was
evenly distributed from 50 to 200 nm.
Tunable Resistive Pulse Sensing
TRPS measurements showed that CEVs isolated using TFF
and ultracentrifugation had a similar size distribution spectrum
(Figure 1G). The size of DEVs isolated using TFF showed a
broad distribution ranging from 70 to 200 nm, while the size
distribution obtained for DEVs isolated using ultracentrifugation
could not be used for comparison due to a much lower sample
concentration (Figure 1H).
The mode sizes of both CEVs and DEVs were consistent
for each individual method (with differences between methods)
regardless of the isolation method. PTA, nFCM, and TRPS
showed that the mode sizes of CEVs and DEVs were around
150, 90, and 110 nm, respectively (Figure 1I). However, DLS
showed differences in mode sizes of CEVs and DEVs depending
on the isolation method. Ultracentrifugation yielded larger
CEVs with mode size around 270 nm, while CEVs isolated
with TFF was approximately 197 nm. Similarly, the mode size
of DEVs isolated using ultracentrifugation was approximately
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FIGURE 1 | Comparison of the size distribution for different isolated extracellular vesicles (EVs). Representative histograms revealing size distribution of extracellular
vesicles derived from chorionic mesenchymal stromal/stem cell (CEVs) and extracellular vesicles derived from decidual mesenchymal stromal/stem cell (DEVs)
isolated using tangential flow filtration (TFF) and ultracentrifugation by four different methods. The size distributions of these EVs were assessed by (A,B) particle
tracking analysis (PTA), (C,D) dynamic light scattering (DLS), (E,F) nano-flow cytometry (nFCM), and (G,H) tunable resistive pulse sensing (TRPS), respectively. The
mode size (I) and concentration (J) of all EV samples were presented. The graphs represent the averaged values based on three repeated measurements of each EV
sample.
1,120 nm, and TFF isolated DEVs was approximately 240 nm.
It is important to notice that the scattering intensity depends
on the 6th power of the size of the macromolecules, therefore,
large agglomerates—even a very small amount will overwhelm
the intensity from small size particles in DLS (Barnett, 1942).
Thus, the observation of small size particles in EVs isolated
using TFF in DLS indicated the substantial amount of small size
particles and the absence of agglomerates in TFF isolated EVs.
To further explore the possibility of the presence of small size
particles in the samples, AF4 was used (Supplementary Figure 2)
to fractionate and measure the hydrodynamic diameter of the
entities as they eluted.
The concentration of EVs was determined using
three techniques: PTA, nFCM, and TRPS (Figure 1J).
The concentration of CEVs isolated using TFF and
ultracentrifugation determined by PTA and nFCM was
approximately 1011 EVs/ml. In contrast, TRPS measured
approximately 1012 CEVs/ml isolated using TFF, one order of
magnitude larger than PTA and nFCM. The concentration of
DEVs isolated using TFF measured using PTA and TRPS was
∼109 EVs/ml, while the measurement made using nFCM was
1011 EVs/ml, two orders of magnitude higher. The concentration
of DEVs isolated using ultracentrifugation was consistent for all
measurement methods, 109 EVs/ml.
In summary, both PTA and nFCM measurements showed
a consistent average size for both DEVs and CEVs regardless
of isolation method; however, the concentration of EVs was
around two orders of magnitude lower for DEVs isolated
using ultracentrifugation. Overall, results suggested that PTA
was less sensitive than nFCM for the detection of EVs
smaller than 100 nm.
Mass Analysis
Besides the size distribution, the buoyant mass and dry mass
of different isolated EVs were quantified. Previously, buoyant
mass and dry mass were used to determine the exact amount of
nanoparticles interacting with cells and tissues in toxicity studies
(Cohen et al., 2013). Here, we used resonant mass measurement
(RMM) for the first time to characterize EVs for buoyant mass
and dry mass. The advantage of this approach is that both
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FIGURE 2 | The dry mass of different isolated EVs, and EV molecular composition was analyzed using nano-flow cytometry (nFCM). The dry mass of TFF and
ultracentrifugation-isolated (A) CEVs and (B) DEVs. LOD, limit of detection. Representative histograms showing the presence of three surface markers CD9, CD63,
and CD81 (C,F,I,L), nucleic acid (D,G,J,M), and lipid content (E,H,K,N) in CEVs and DEVs isolated using TFF and ultracentrifugation. The arrow indicates the
saturated fluorescence peak. MFI, mean fluorescence intensity.
mass parameters can be measured for individual vesicles, which
in turn reveals the total mass, including molecular cargo, of
each vesicle (Rupert et al., 2017). Precise knowledge of the
amount of EV cargo is pivotal to define the biological function
of EVs.
The dry mass of EVs isolated using ultracentrifugation
and TFF was measured and presented in Figures 2A,B. The
size distribution of each EV type was calculated from the
measured buoyant mass, with a particle density of 1.4 g/cm3
(Supplementary Figure 3). It is important to notice that the
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limit of detection (LOD) of RMM for dry mass is 10−15 g,
and for size distribution, it is 100 nm. Therefore, only sub-
population of EVs with the high mass was detected and measured.
When plotted as a function of dry mass, both detectable CEVs
and DEVs isolated using ultracentrifugation showed higher
dry mass than EVs isolated using TFF (Figure 2). The dry
mass of measurable CEVs isolated using ultracentrifugation
(4.67 × 10−15 g) was higher than CEVs isolated using TFF
(3.17 × 10−15 g) (Figure 2A). Similarly, measurable DEVs
isolated using ultracentrifugation (7.43 × 10−15 g) showed
higher dry mass than DEVs isolated using TFF (3.9 × 10−15 g)
(Figure 2B). Interestingly, a sub-population of DEVs isolated
using TFF, which has a positive buoyancy was detected, and its
size was estimated using a density of 0.01 g/cm3 (Supplementary
Figure 3). This positively buoyant sub-population of DEVs
isolated using TFF could be bubbles or empty vesicles. The higher
mass for detectable EVs (above 100 nm) (CEVs and DEVs)
isolated using ultracentrifugation suggested the presence of more
agglomerates in ultracentrifugation-isolated EVs.
Cumulatively, size and mass measurements suggested that
these EVs contained some amounts of agglomerates. The
agglomeration of EVs during ultracentrifugation was reported in
previous studies (Linares et al., 2015; Nordin et al., 2015; Taylor
and Shah, 2015).
Extracellular Vesicle Molecular
Composition Assessed Using Nano-Flow
Cytometry and Nanoscale Infrared
Spectroscopy
Extracellular Vesicle Surface Markers
The differences in the dry mass of EVs isolated using
ultracentrifugation, and TFF suggested that there were
differences in molecular composition of EVs. Therefore, we
assessed the presence of three common EV surface markers
(i.e., CD9, CD63, and CD81) on different isolated EVs by
using nFCM. CD9, CD63, and CD81-positive were EVs
defined as the events that were above the threshold level
and detected by fluorescence triggering (Supplementary
Figure 4). A control using basal medium with 0.5% (w/v)
BSA (Supplementary Figure 4) showed negligible fluorescence
in fluorescence triggering, which demonstrated that the free
dye was successfully removed by our washing procedure.
The histogram analyses showed that both CEVs and DEVs
regardless of isolation method were positive for CD9, CD63,
and CD81 (Figures 2C,F,I,L). The overall mean fluorescence
intensity (MFI) of CD9, CD63, and CD81 was higher for CEVs
isolated using the same method. Profile analysis of individual
surface markers showed that their expression was not uniform
across different sub-populations of EVs. CD9 was detected
as strongly positive in CEVs isolated using TFF (MFI: 718),
followed by CD63 (MFI: 595) and CD81 (MFI: 514) (Figure 2C),
whereas the expression of CD9 (MFI: 874) and CD81 (MFI:
700) was higher than CD63 (MFI: 364) in CEVs isolated using
ultracentrifugation (Figure 2F).
The expression of the markers was more uniform for DEVs
than CEVs when using the same isolation method. All three
markers of DEVs isolated using TFF were uniformly detected
at a low MFI level (under 200) (Figure 2I). Specifically, the
MFI value for CD9 (178) was higher than CD63 and CD81
(121 and 120, respectively). Since DEVs isolated using TFF had
a substantial amount of small size particles (∼8 and 200 nm)
assessed using DLS, the expressions of the markers were lowest.
Meanwhile, DEVs isolated using ultracentrifugation showed a
higher expression of the markers than TFF. The MFI values for
CD9, CD63, and CD81 were 494, 535, and 528, respectively, in
DEVs isolated using ultracentrifugation (Figure 2L).
The profile of the surface markers for EVs isolated from
each of the cell type was different depending on the isolation
method. This result suggested that each of the isolation method
provided different EV populations. However, regardless of the
isolation method, EVs isolated from DMSC23 consistently
showed more uniform expression of all three markers, which
implied that exosome-specific markers were more homogenously
expressed on DEVs.
Nucleic Acid Profiling
We next quantify the total nucleic acid content inside EVs
by staining EVs with SYTO RNASelect green fluorescent cell
stain. The percentage of nucleic acid was calculated by dividing
the concentration of SYTO RNASelect green-positive events by
the total concentration of EVs (Table 1). EVs isolated using
TFF were diluted 50 times before staining to achieve the same
threshold level as EVs isolated using ultracentrifugation. Since
TFF isolated EVs were diluted, a smaller fluorescence intensity
peak was shown in CEVs isolated using TFF in comparison
with CEVs isolated using ultracentrifugation (Figures 2D,G).
However, the analyses after the calculation showed that CEVs
isolated using TFF contained 22 times more of the nucleic acid
(2.46%) than CEVs isolated using ultracentrifugation (0.11%)
(Table 1). Similarly, the nucleic acid content of DEVs isolated
using TFF (3.31%) was seven times higher than DEVs isolated
using ultracentrifugation (0.46%) (Table 1 and Figures 2J,M).
Overall, we concluded that the total amount of nucleic acid in
DEVs was higher than CEVs when using the same isolation
method. The low percentage of SYTO RNASelect green-positive
events could be due to the low amount of RNA inside
EVs. Moreover, since the nucleic acids are considered to be
small molecules and may have low fluorescence intensities, the
fluorescence events from the nucleic acid may fall below the
detection limit of nFCM.
TABLE 1 | The percentage of nucleic acid content in extracellular vesicles derived
from chorionic mesenchymal stromal/stem cell (CEVs) and extracellular vesicles
derived from decidual mesenchymal stromal/stem cell (DEVs) isolated using
tangential flow filtration (TFF) and ultracentrifugation assessed using nano-flow
cytometry (nFCM).
EV type Percentage of nucleic acid (%)
CEVs TFF 2.46
CEVs ultra 0.11
DEVs TFF 3.31
DEVs ultra 0.46
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Lipid Membrane Profiling
We next assessed the lipid content in each EV type by staining
EVs with green fluorescence lipophilic dye, PKH67. PKH67,
which labels the cell membrane by inserting its aliphatic chains
into the lipid membrane, has been used extensively to label
the lipid membrane of EVs (Ohno et al., 2013). The lipid
compositions of DEVs and CEVs were measured and compared
with two controls: basal medium only (BM) and basal medium
with 0.5% (w/v) BSA (BM+ 0.5% BSA) (Figure 2). We used two
controls as PKH67 may label other components in the medium
(non-specific binding) (Lai et al., 2015; Takov et al., 2017). Hence,
two control groups were essential to eliminate false positives due
to fluorescence from non-EV components.
The total fluorescence events of CEVs isolated using TFF
(2,995 events) was nine- and 35-fold higher than BM (84 events)
and BM + 0.5% BSA (331 events) (Figure 2E), which showed
substantial PKH67-positive EVs. On the other hand, CEVs
isolated using ultracentrifugation (492 events) had 221 more
fluorescence events than BM (281 events), but they had 665 less
events than BM + 0.5% BSA (1,157 events) (Figure 2H). The
fluorescence-positive events in controls indicated that there were
some “contaminants” in the controls, which bound to PKH67
and caused the fluorescence. The saturated fluorescence intensity
peak in CEVs isolated using ultracentrifugation, which was not
detected in controls, suggested the presence of larger size vesicles
or agglomerates (Figure 2H; arrow).
The total fluorescence events of DEVs isolated using TFF
(467 events) were approximately twofold lower than BM (880
events) and BM + 0.5% BSA (930 events) (Figure 2K). DEVs
isolated using ultracentrifugation (1,972 events) had 1,685 and
1,567 more events than BM (287 events) and BM + 0.5% BSA
(405 events), respectively (Figure 2N). This result indicated
that DEVs isolated using ultracentrifugation contained a high
concentration of PKH67-positive EVs. Since DEVs isolated using
ultracentrifugation had the lowest concentration of EVs among
all EV groups, this result could be a false-positive result. One
possible explanation could be that during ultracentrifugation,
lipid–protein aggregates and other media components are
isolated beside EVs. These undesired components can potentially
bind PKH67, which causes a misleading result.
As observed in Figures 2H,N, the number of events shown
in the controls (BM and BM + 0.5% BSA) emphasized the non-
selective binding of PKH67 to other components. These results
are consistent with the findings that the PKH67 lipophilic dyes
is not specific to EVs (Lai et al., 2015). Therefore, this study was
inconclusive regarding to the amount of lipid of EV isolates.
Molecular Composition of Individual
Extracellular Vesicles Using Nanoscale
Infrared Spectroscopy
While nFCM proved to be a very effective method to determine
size and composition of EVs at bulk population level, this
method, similar to other size measurements methods, cannot
effectively distinguish between a single large EV and an
agglomerate of several small EVs (Linares et al., 2015). Therefore,
to characterize EVs at single vesicle level, we used nanoscale
infrared spectroscopy (AFM-IR) (Figure 3; Kim et al., 2018,
2019b). Topographical AFM images showed that both CEVs
and DEVs were spherical and their size ranged between 20 and
300 nm regardless of isolation method (Figure 3A). Molecular
analysis at the single vesicle level employed state-of-the-art
nanoscale infrared spectroscopy (AFM-IR), which showed that
individual EVs contained proteins, nucleic acids, and lipids
(Supplementary Figure 5 and Figures 3B,C). However, the
compositions of both types of EVs were different depending on
the isolation method.
The spectra of CEVs isolated using TFF had dominant peaks
for all three main components of EVs: protein (1,670, 1,544,
and 1,260 cm−1), nucleic acid (1,450, 1,404, and 1,320 cm−1),
and lipid (1,105 and 1,020 cm−1), which confirmed the presence
of all three components in individual EVs (Lee et al., 2017).
The intensity ratio of protein amide I (1,670 cm−1) and amide
II (1,544 cm−1) was 2:1, which indicated ordinary protein
conformation in CEVs isolated using TFF. Peaks at 1,450 and
1,404 cm−1 in the spectra of CEVs isolated using TFF were
attributed to phosphatidylcholine head group and thymine of
RNAs (Kim et al., 2019b). In contrast, the spectra of CEVs isolated
using ultracentrifugation had a broad band with low intensity
in amide I peak at 1,660 cm−1. They also showed a dominant
peak at 1,068 cm−1 (lipid) and five minor peaks at 1,768, 1,560,
1,480, 1,296, and 1,248 cm−1. Since the intensity of amide II
peak (1,560 cm−1) was low in the spectra of CEVs isolated
using ultracentrifugation, it suggested that protein conformation
for these EVs was altered. Moreover, the absence of peaks in
the 1,450–1,350 cm−1 region in the spectra of CEVs isolated
using ultracentrifugation suggested smaller amounts of nucleic
acid (i.e., RNAs), which was consistent with the nFCM result
(Table 1). The dominant peak at ∼1,068 cm−1 in the spectra
of CEVs isolated using ultracentrifugation was associated with
the ester C–O–C symmetric stretching vibration (Mohan et al.,
2020). This peak was shifted to ∼1,105 cm−1 in the spectra
of CEVs isolated using TFF. The peak at 1,768 cm−1 in the
spectra of CEVs isolated using ultracentrifugation could be
related to ester groups, primarily from lipid and fatty acids
(Kim et al., 2018).
The spectra of DEVs isolated using TFF characterized showed
dominant peaks at 1,624, 1,544, 1,256 cm−1, and a shoulder
at 1,672 cm−1 (protein), 1,450, 1,392 cm−1 (nucleic acid), and
1,080 and 1,040 cm−1 (lipid). The intensity ratio of amide I
(1,624 cm−1) and amide II (1,544 cm−1) peaks was ∼2:1, which
suggested unaltered protein conformation in the spectra of DEVs
isolated using TFF. Peaks at 1,450 and 1,392 cm−1 in the spectra
of DEVs isolated using TFF confirmed the presence of RNAs
(Kim et al., 2019b). In contrast, the spectra of DEVs isolated
using ultracentrifugation had dominating peaks at 1,592 cm−1
(protein amide II), 1,280 cm−1 (nucleic acid, protein), and
broad bands at 1,680, 1,440, and 1,164 cm−1. The low intensity
of the amide I (1,680 cm−1) peak in the spectra of DEVs
isolated using ultracentrifugation suggested some alterations in
protein structures of these EVs. The broad band with low
intensity at 1,440 cm−1 in the spectra of DEVs isolated using
ultracentrifugation suggested a reduced amount of RNAs, which
was consistent with the nFCM result (Table 1). In addition,
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FIGURE 3 | Average infrared absorption spectra of extracellular vesicle (EV) molecular composition corresponding topographical atomic force microscopy (AFM)
images for EVs. (A) AFM images (10 × 5 µm) of individual EVs (indicated as white protrusions) deposited on prism. Normalization of the average AFM-IR spectra of
(B) CEVs isolated using TFF and ultracentrifugation; (C) DEVs isolated using TFF and ultracentrifugation. At least 15 individual EVs were randomly selected and
analyzed using Analysis StudioTM software.
the bands in the 1,080–1,040 cm−1 region were associated with
vibration from phosphate stretch of RNA/DNA or lipid (Balan
et al., 2019). While the spectra of DEVs isolated using TFF had
two peaks at 1,080 and 1,040 cm−1, the spectra of DEVs isolated
using ultracentrifugation only had one peak at 1,060 cm−1
suggesting changes in RNA/DNA structures and lipid. The
peak at 1,712 cm−1 in the spectra of DEVs isolated using
ultracentrifugation could be related to ester groups, primarily
from lipid and fatty acids.
Overall, the structures of all three key molecular/structural
components of EVs, proteins, lipids, and nucleic acid were
maintained in the spectra of both CEVs and DEVs isolated
using TFF. In contrast, for the spectra of EVs isolated
using ultracentrifugation, the intensity, position, and the width
of the peaks changed, indicating changes to the molecular
structure of these components. These changes were observed for
both CEVs and DEVs.
Since both nucleic acid and lipid peaks are centered around
the same frequency, it was necessary to validate the results
using an alternative technique, e.g., nFCM. We showed that
the amount of nucleic acid in the spectra of EVs isolated
using ultracentrifugation was smaller than TFF regardless of
the origin of EVs, which was consistent with the nFCM
result. Therefore, combining both nFCM and nanoscale infrared
spectroscopy are necessary to gain precise understanding of the
molecular/structural composition of individual EVs.
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Predicted Sedimentation of Isolated
Extracellular Vesicles Using Distorted
Grid Model
The differences in physicochemical properties of EV types
suggested that their colloidal stability, interactions with the cell
membrane, internalization, and downstream biological effects
could also be different (Willms et al., 2018). While largely ignored,
the colloidal stability is a critical parameter that shows ability
of EVs to move toward, and reach cells (“sediment”), hence,
likely to affect the biological effectiveness of EVs. The transport
modeling for EVs was completed for the first time based on their
size, size distribution, effective density to calculate the particles
sedimentation, and diffusion in cell culture media.
The predicted sedimentation of different EV isolates was
assessed using the DG model. All the values used for the modeling
are shown in Supplementary Table 2. The results indicated the
differences in sedimentation between EVs depending on the
isolation method (Figure 4). CEVs isolated using TFF showed
that the deposited fraction was predicted to reach 0.00354 within
1 h, then slowly reach the mean fraction deposited (0.003587)
after ∼10 h (Figure 4B). Meanwhile, CEVs isolated using
ultracentrifugation was predicted to reach the mean fraction
deposited (0.2169) after ∼7.5 h (Figure 4D). For DEVs, the
mean fraction deposit was predicted to be reached after ∼8 h
for EVs isolated using TFF (0.003588)(Figure 4C) and ∼10 h
for EVs isolated using ultracentrifugation (0.3198)(Figure 4E).
Overall, the mean of fraction deposit of EVs isolated using
ultracentrifugation was 65 and 100 times higher than EVs
isolated using TFF for CEVs and DEVs, respectively. A previous
study reported that less agglomeration resulted in a smaller
deposited fraction (DeLoid et al., 2015), which confirmed
that EVs isolated using TFF do not contain agglomerates. In
contrast, EVs isolated using ultracentrifugation may contain
the agglomerates, and these agglomerates could be attributed
to the higher sedimentation. This result was consistent
with our size distribution (DLS), mass (RMM), and the
visualization of EV (holotomography) internalization by a single
cell (see below).
Extracellular Vesicles Internalization by
Living BEAS-2B Cells Using
Holotomography
To attest the relevance of the predicted sedimentation study
in assessing EV uptake, we used EVs isolated using TFF
and ultracentrifugation and visualized their presence in
and on single cells using correlative holotomography and
fluorescence microscopy (Figure 5). This method, unlike
confocal microscopy, does not require any fluorescent labeling
for cells, which imparted no stress on cells. Additionally,
holotomography microscopy enables us to visualize the
differences in refractive index; thus, we can observe subcellular
organelles of the cells without labeling with nanometer resolution
(Kim et al., 2020).
DEVs isolated using TFF had a substantial amount of
small size particles (Figure 1), which caused the difficulties
in visualizing EVs. Therefore, to demonstrate the differences
between TFF and ultracentrifugation-isolated EVs, the EVs
localization study using a holotomography microscope was
conducted only for CEVs. BEAS-2B cells were dosed with
PKH67-labeled CEVs and imaged 3 h later. We observed
fluorescence inside the cells and not on the plasma membrane,
which suggested that EVs were internalized by the cells. In
order to confirm whether EVs are inside cell cytoplasm,
we used digital staining for cells and processed them into
dynamic 3D images based on the rotation of one axis
(Supplementary Video 1). The analysis of the dynamic
images evidenced that EVs were internalized by BEAS-2B
cells after 3 h. The results showed that the punctate CEVs
isolated using TFF were qualitatively and homogenously
distributed in the cytoplasm (Figure 5A) and are of uniform
sizes. The size of CEVs isolated using ultracentrifugation
were heterogenous, ranging from 100 to 500 nm (Figure 5B).
These observations confirmed agglomeration had occurred
during ultracentrifugation. The control experiment using
BM + 0.5% BSA showed no fluorescently labeled particles
(data not shown).
Cell Migration Assay With Different
Concentrations of Isolated Extracellular
Vesicles
The actual biological effects of different EV isolates were
investigated using the scratch wound assay, which was modified
to measure the wound closure of cells toward the “wound.”
Lung epithelial cells (BEAS-2B) were selected, and 10 µg/ml
of lipopolysaccharides (LPS) was used before wound scratch
as an in vitro model of acute lung injury. LPS is a key
pathogenic factor that induces various inflammatory mediators,
which resulted in lung inflammatory and epithelial damage
(Nova et al., 2019). Concentrations of CEVs and DEVs isolated
using TFF and ultracentrifugation, ranging from 10 to 1,000
EVs per cell, were used in order to test their ability to
promote cell migration and increase wound closure after
injury. Both CEV- and DEV-treated cells enhanced wound
closure percentage when compared with LPS-treated only cells
(Figure 6). Increasing the concentration of CEVs isolated using
both TFF and ultracentrifugation (from 10 to 1,000 EVs per
cell) increased the wound closure percentage of BEAS-2B cells
(Figures 6A,C). Especially, at the concentration of 10 EVs per
cell for CEVs isolated using TFF, the wound closure percentage
was significantly increased compared with LPS-treated only
cells (Figure 6A).
Treatment with DEVs isolated using TFF resulted in increased
wound closure percentage of BEAS-2B cells (Figure 6B). The
wound closure percentage of BEAS-2B was significantly increased
at the concentration of 100 and 1,000 EVs per cell for DEVs
isolated using TFF. In contrast, with a high concentration of
DEVs isolated using ultracentrifugation (100 and 1,000 EVs per
cell), the wound closure percentage remains as low as the LPS-
treated cells (Figure 6D). This was supported by the highest
sedimented amount for DEVs isolated using ultracentrifugation
using the DG model, which resulted in the highest dose for cells.
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FIGURE 4 | Schematic overview of nanodosimetry approach and the predicted fraction deposited of EVs. The schematic overview of DG modeling adapted from
DeLoid et al. (2017) (A). The predicted fraction deposited of CEVs isolated using (B) TFF and (D) ultracentrifugation; DEVs isolated using (C) TFF and (E)
ultracentrifugation into each well in a 96-well plate was generated by Matlab. Mean fD is the mean fraction deposited.
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FIGURE 5 | The localization of EVs with BEAS-2B cells. Three representative images of BEAS-2B cells and stained CEVs (green color) isolated using (A) TFF and (B)
ultracentrifugation. Scale bar represents 10 µm. Bright white dots inside BEAS-2B cells indicate the lipid droplets.
We postulate that the high DEV dose could be causing adverse
effects on the cells.
Cellular Stress After Injury in Response
to Different Concentration of Isolated
Extracellular Vesicles
Nitric oxide (NO) measurement allows the measurement of
cellular stress levels in response to injury (Nasyrova et al.,
2015). NO participates in diverse physiological and pathological
processes, such as inflammation (van der Vliet et al., 2000). In
response to inflammatory stimuli, NO production is markedly
elevated (Coleman, 2001). Given the importance in studying
and understanding NO for health and disease, a number of
fluorescent sensors have been reported to date (Iverson et al.,
2018). However, a common feature of small molecule sensors is
poor water solubility, arising from the highly aromatic structures.
This has two main drawbacks in cellular studies: first, a need
to prepare a stock solution of the dye in an organic solvent
such as dimethyl sulfoxide (DMSO), which itself can perturb
the system, and second, a tendency for the dye to aggregate
and self-quench. We therefore sought to prepare a water-soluble
fluorescent sensor for NO by utilizing the previously-reported
selective conversion of aromatic ortho-diamines to triazoles in
the presence of nitric oxide and oxygen (Iverson et al., 2018),
conjugating this reactive group to a 4-amino-1,8-naphthalimide
fluorophore, which we have previously shown to have great
potential for sensing applications (Leslie et al., 2018; Yang
et al., 2018). Water solubility was achieved by incorporating a
triethylene glycol (TEG) group to give the final probe, NpNO1
(Figure 7A). NpNO1 was prepared in four synthetic steps from
commercially available bromoacetic naphthalic anhydride, in
42% overall yield as detailed in the Supplementary Information
(Scheme 1). NpNO1 was found to have excellent aqueous
solubility up to 1 mM (Supplementary Figure 6) and a strong
fluorescence turn-on at 455 nm with NO addition (Figure 7B).
The ability of NpNO1 to detect changes in intracellular NO
levels by confocal microscopy was confirmed in A549 (human
alveolar basal epithelial) cells treated with 50 µM of NpNO1
overnight, in the presence or absence of 5 mM MAHMA
NONOate (Figure 7C and Supplementary Figure 6). MAHMA
NONOate spontaneously releases NO and, hereafter, will be
referred to as the NO donor. We observed minimal/basal
fluorescence from untreated cells (no stain), cells treated with
only MAHMA NONOate, or cells treated with NpNO1 alone.
In A549 cells treated with both the NpNO1 and the NO donor,
we observed fluorescent puncta in every cell, and a significant
increase in mean fluorescence intensity.
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FIGURE 6 | Assessment of wound closure in injured BEAS-2B in response to EV treatment. BEAS-2B cells were “injured” with 10 µg/ml of LPS and treated with
CEVs isolated using (A) TFF and (C) ultracentrifugation; DEVs isolated using (B) TFF and (D) ultracentrifugation. Error bars represent standard deviation (SD), n = 8.
Statistics significance was determined by ordinary one-way ANOVA test, followed by Dunn’s multiple comparisons test for pair-wise comparisons. Statistical
significance shown was between LPS treatment and other groups at time point 12 h. ∗P < 0.1; ∗∗P < 0.01; ∗∗∗∗P < 0.0001; NS, not significant.
We then assessed intracellular NO levels after adding various
EVs, by quantifying the NpNO1 fluorescence intensity in cells
imaged using confocal microscopy (Supplementary Figure 7).
Similar to the scratch wound assay, we modeled cellular injury
by treating human BEAS-2B epithelial cells with 10 µg/ml of
LPS. The intracellular NO, as indicated by the fluorescence
intensity of NpNO1, increases after LPS injury (Figure 7), which
is consistent with the literature (Chokshi et al., 2008). Next, we
assessed the fluorescence intensity of NpNO1, which corresponds
to the levels of intracellular NO present, in LPS-treated cells
dosed with various isolated EVs. Upon adding the concentration
of 10–1,000 EVs/cells for CEVs isolated using TFF, the NO
levels diminished compared with LPS-treated cells (Figure 7E),
whereas, dosing the LPS-treated cells with 10 EVs/cell for
CEVs isolated using ultracentrifugation, the intracellular NO
levels remain high, as in the LPS-treated cells (Figure 7E). The
intracellular NO levels decreased when 100 and 1,000 EVs/cells
for CEVs isolated using ultracentrifugation were added compared
with LPS-treated cells.
The NpNO1 fluorescence intensity remained as high as LPS-
treated cells using the concentration of 10 DEVs/cell isolated
using TFF (Figure 7F). The intracellular NO levels, as indicated
by NpNO1 fluorescence intensity, decreased when the cells
were treated with 100 and 1,000 DEVs isolated using TFF.
For DEVs isolated using ultracentrifugation, the intracellular
NO levels remain as high as the LPS-treated cells at all
concentrations (Figure 7F).
DISCUSSION
While there is palpable excitement about the future of EV-based
medicine, a current major limitation is the lack of understanding
about how to effectively and uniformly isolate them from
complex biological milieu (Li et al., 2019). Furthermore,
it has not been clear whether different isolation methods
extract different sub-populations of EVs, which would impact
on their downstream applications. This gap in knowledge
is associated with conceptual and technical limitations in
EV characterization. We have addressed this challenge by
using multiple techniques including optical, non-optical, and
high-resolution single vesicle characterization methods, and
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FIGURE 7 | A novel, water soluble fluorescent sensor for intracellular nitric oxide (NO) and assessing NO levels in BEAS-2B cells. (A) Water-soluble NO sensor
NpNO1 and the product of its reaction with nitric oxide to give a fluorescent triazole derivative. (B) Fluorescence emission response of NpNO1 (10 µM) in the
presence of diethylamine NONOate (1 mM). (C) Representative micrographs of A549 cells treated with NpNO1 (50 µM) in the absence (left) and presence (right) of
MAHMA NONOate (5 mM). Scale bar represents 50 µm. (D) Mean fluorescence intensity of A549 cells treated as indicated measured across at least three different
field of views in each of the three independent experiments performed (n = 3). MAHMA NONOate, (Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}diazen-
1-ium-1,2-diolate, an NO donor. BEAS-2B cells were “injured” with 10 µg/ml of LPS and dosed with (E) CEVs isolated using TFF and ultracentrifugation and (F)
DEVs isolated using TFF and ultracentrifugation. Statistical significance was determined by ordinary one-way ANOVA, followed by Dunn’s multiple comparisons test
for pair-wise comparisons, n = 3. Statistical significance shown was between LPS treatment and other groups. ∗P < 0.1; ∗∗P < 0.01; ∗∗∗P < 0.001;
∗∗∗∗P < 0.0001; NS, not significant. Error bars denote standard deviation (SD). The dash line represents the mean level of the LPS group.
we provide extensive experimental evidence that isolation
method determines the composition and biological function
of EV isolates.
Two common isolation methods were used in this study:
ultracentrifugation and TFF. Using four different techniques,
we demonstrated that the size distributions of EVs isolated
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using ultracentrifugation and TFF were different. Since EVs
are heterogenous and each characterization technique has its
own limits of detection (Gandham et al., 2020), it is essential
to measure the size distribution using multiple techniques.
Here we used four techniques to measure the size distribution
and concentration of EVs including PTA, DLS, nFCM, and
TRPS. PTA is based on light scattering and Brownian motion,
which cannot differentiate between large protein aggregates and
single large particles (Gercel-Taylor et al., 2012). For DLS, the
size distribution depends on the intensity of light scattering;
therefore, the intensity of the scattered light from small particles
is normally surpassed by large particles (Tosi et al., 2020). Hence,
DLS is not suitable to provide the accurate size distribution for
heterogenous populations. In addition, many EVs have protein
corona on their surfaces, which may impact on the accuracy of
the results as EVs with and without corona (or unspecific corona)
have different hydrodynamic diameters (Varga et al., 2020).
Similar to PTA and DLS, nFCM is based on the light scattering
from the samples. However, nFCM detects the light scattering
from individual nanoparticles passing through the lasers, which
prevents the bulk analysis of samples like PTA and DLS. In
addition, with the incorporation of multiparameter fluorescence
detection, nFCM allows the size detection of individual EVs down
to 40 nm (Tian et al., 2018; Gandham et al., 2020). However, the
large particles or agglomerates (>200 nm) could not be detected
using nFCM since the size distribution of EVs was calibrated
based on the size standard of a mixture of silica nanospheres,
which was below 200 nm. Finally, we used TRPS with a nanopore
NP100, which was calibrated to measure nanoparticles in the
range between 50 and 300 nm. Since TRPS detects vesicles
within the range of the selected nanopore (Maas et al., 2015),
TRPS was less sensitive for detection of EV particles below
50 nm. Size and concentration measurement results showed
that each characterization technique has its own limitations
due to principles of the measurement, the way samples are
prepared, as well as calibration standards (for nFCM and TRPS).
Consequently, it led to discrepancies between the results obtained
with each of the techniques. These findings highlighted the need
to use multiple and complementary techniques to capture the
whole population of EVs. Our study also emphasized the need
for the careful interpretation of the measurement results, which
should account for theoretical and physical principles of each
technique, sample preparation, and sample state, which all can
impact on the results.
In addition, for the first time, we have demonstrated that
large EVs (>100 nm) isolated using ultracentrifugation have a
higher dry mass than large EVs isolated using TFF. Here we
have introduced the parameter of EV dry mass as a metric to
reveal the total mass of molecular cargo inside each vesicle,
a measurement not previously made in the EV field. The
differences in dry mass between EV isolates suggested different
molecular compositions. Indeed, we showed that there were
variations between the expression levels of surface markers
(CD9, CD63, and CD81) between different EV isolates at sub-
population level by using nano-flow cytometry. It has been
reported that the presence of each surface marker in EV
populations was different depending on the isolation methods
of EVs (Tian et al., 2020), which clearly indicated that different
subpopulations of EVs have been extracted using different
isolation methods. Furthermore, our study showed that the
amount of nucleic acid content in EVs isolated using TFF was
higher than in EVs isolated using ultracentrifugation for both EV
types. The higher nucleic acid content for EVs isolated using TFF
was further confirmed at individual vesicle characterization using
atomic force nanoscale infrared spectroscopy. By combining
multiscale characterization techniques, our study allows robust
and precise quantification of molecular composition of EVs. This
methodology goes a step beyond conventional characterization
methods such as immunoassays or mass spectroscopy, which
not only lack single vesicle and subpopulation resolution and
flexibility in practical applications but also are very expensive
(Trenchevska et al., 2016). This study paves the way to the future
diagnostic and therapeutic applications of EVs that depend on
identification/quantification of specific cargo.
We have also showed for the first time that the variations in
the physicochemical properties of different EV types correlate
to their different interactions with cell membranes. By using
a distorted grid model to predict how quickly different
types of EVs can reach the cell membrane, we demonstrated
that the predicted sedimented amount of EVs isolated using
ultracentrifugation were 60–100 times higher than EVs isolated
using TFF. The calculated higher sedimentation of EVs isolated
using ultracentrifugation is likely to be due to the presence of
agglomerates, which was consistent with the size distribution
and mass results. The agglomerates in EVs isolated using
ultracentrifugation were confirmed further using correlative
holotomography and fluorescence microscopy. The results of the
sedimentation study predict the amount of EVs, which is likely
to reach and interact with cells. Depending on the amount of
internalized EVs, there may be beneficial or deleterious effects in
recipient cells. For example, we showed that DEVs isolated using
ultracentrifugation had the highest predicted sedimentation and
induced both decreased cell migration and high intracellular NO
levels, which indicated an increase in cellular stress post-injury.
However, these undesired effects could be associated with EV
agglomerates that sedimented rapidly to the cell surface, or with
“contaminations” that are typically co-isolated with EV samples
during ultracentrifugation. Differences in biological responses to
different EV isolates were confirmed using newly developed nitric
oxide (NO) probe, which allowed for quantitative and qualitative
assessment of intracellular stress (Nasyrova et al., 2015). NO
probe enabled us to determine the ability of each EV isolates to
promote cell recovery from injury.
In conclusion, we have shown that the physicochemical
properties, molecular composition, presence of surface
markers, and subsequent biological effects of EVs isolated
using ultracentrifugation are markedly different from those
isolated by TFF. This study confirms that the isolation method
determines which composition of EV sub-populations is isolated.
Demonstrated here is the correlation between physicochemical
properties and biological effects of EVs, which confirmed that
the downstream applications of EVs are determined by the
effectiveness of the isolation methods to isolate and fractionate
different subpopulations of EVs.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 17 June 2021 | Volume 9 | Article 669537
fbioe-09-669537 June 1, 2021 Time: 18:49 # 18
Phan et al. Multiscale Characterization of EVs
The methodology that we present here for the high-resolution
and multiscale measurement of physicochemical and functional
properties of EVs is likely to accelerate progress in the
development and refinement of isolation methods. Our findings,
which uncovered that different EV subpopulations are isolated
by different methods, shed new light in our understanding of
EV secretion by cells. Furthermore, knowing what the differences
in EV composition are depending on the isolation method
will support the development of accurate EV-based diagnostic
tools for early disease detection. We will also be able to define
populations of EVs which have therapeutic potential for specific
medical conditions. Taken together, the presented study advanced
current understanding of the effect of isolation methods on
EV composition and functionality. Our results are likely to
contribute to future EV research and provide a backbone for
rapid translation of EVs to practical applications.
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